أعرض في EDS

Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma

التفاصيل البيبلوغرافية
العنوان:	Comparative Efficacy of Teclistamab Versus Physician's Choice of Therapy in the Long-term Follow-up of APOLLO, POLLUX, CASTOR, and EQUULEUS Clinical Trials in Patients With Triple-class Exposed Relapsed or Refractory Multiple Myeloma
المؤلفون:	María-Victoria Mateos, Ajai Chari, Saad Z. Usmani, Hartmut Goldschmidt, Katja Weisel, Keqin Qi, Anil Londhe, Sandhya Nair, Xiwu Lin, Lixia Pei, Eric Ammann, Rachel Kobos, Jennifer Smit, Trilok Parekh, Alexander Marshall, Mary Slavcev, Philippe Moreau
المصدر:	Clinical Lymphoma Myeloma and Leukemia. 23:385-393
بيانات النشر:	Elsevier BV, 2023.
سنة النشر:	2023
مصطلحات موضوعية:	Cancer Research, Oncology, Hematology
تدمد:	2152-2650
DOI:	10.1016/j.clml.2023.02.006
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::0fd13d13ccf60a28613b5ee2c9ca4b49 https://doi.org/10.1016/j.clml.2023.02.006
Rights:	CLOSED
رقم الانضمام:	edsair.doi...........0fd13d13ccf60a28613b5ee2c9ca4b49
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	21522650
DOI:	10.1016/j.clml.2023.02.006